| |
| |
|
| Insider
Information: |
Knowles Julius |
| Relationship: |
Director |
| City: |
Lexington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
232,727 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
232,727 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Keros Therapeutics, Inc. |
KROS |
Director |
|
0 |
2022-01-05 |
232,727 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
39 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2020-04-07 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
230,382 |
|
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2020-04-13 |
4 |
A |
$0.00 |
$0 |
I/I |
915,725 |
458,442 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2020-04-13 |
4 |
B |
$20.98 |
$24,987 |
D/D |
1,191 |
1,191 |
2.39 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-02-11 |
4 |
AS |
$62.79 |
$749,441 |
I/I |
(11,561) |
453,878 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-02-12 |
4 |
AS |
$60.20 |
$459,495 |
I/I |
(7,468) |
450,930 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-02-16 |
4 |
AS |
$58.48 |
$575,671 |
I/I |
(9,612) |
447,136 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-02-17 |
4 |
AS |
$58.74 |
$980,588 |
I/I |
(16,061) |
440,796 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-02-18 |
4 |
AS |
$60.06 |
$185,785 |
I/I |
(2,944) |
439,634 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-03-01 |
4 |
AS |
$61.33 |
$818,793 |
I/I |
(12,979) |
434,511 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-03-02 |
4 |
AS |
$57.93 |
$629,285 |
I/I |
(10,711) |
430,283 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-03-03 |
4 |
AS |
$55.91 |
$707,115 |
I/I |
(12,327) |
425,417 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-03-04 |
4 |
AS |
$54.22 |
$645,385 |
I/I |
(11,632) |
420,825 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-04-06 |
4 |
AS |
$58.22 |
$546,840 |
I/I |
(9,298) |
402,015 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-05-03 |
4 |
AS |
$56.04 |
$2,575,992 |
I/I |
(44,816) |
384,324 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-05-04 |
4 |
AS |
$53.73 |
$152,857 |
I/I |
(2,835) |
383,205 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-06-01 |
4 |
AS |
$51.90 |
$462,686 |
I/I |
(8,812) |
379,726 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-06-02 |
4 |
AS |
$48.35 |
$562,138 |
I/I |
(11,529) |
375,175 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-06-03 |
4 |
AS |
$47.69 |
$378,730 |
I/I |
(7,895) |
372,059 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-06-04 |
4 |
AS |
$47.23 |
$314,162 |
I/I |
(6,619) |
369,446 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-06-07 |
4 |
AS |
$46.48 |
$638,451 |
I/I |
(12,796) |
364,395 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-07-01 |
4 |
AS |
$41.22 |
$983,787 |
I/I |
(23,834) |
354,987 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-07-02 |
4 |
AS |
$41.08 |
$984,565 |
I/I |
(23,818) |
345,585 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-09-27 |
4 |
AS |
$40.51 |
$3,924,003 |
I/I |
(95,302) |
307,966 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-10-01 |
4 |
AS |
$40.16 |
$253,932 |
I/I |
(6,323) |
305,470 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Director |
– • – |
2021-10-04 |
4 |
AS |
$40.06 |
$150,065 |
I/I |
(3,746) |
303,991 |
0 |
- |
|
39 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
